CytoMed Therapeutics Ltd
GDTC · XNASCIK 1873093fmd_03BRGKE9AFKV5DCNNFMK4P12XNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2025, 6 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 0 |
| Research and development | 1 | 1 | 2 | 2 | 2 | 2 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | (2) | (2) | (3) | (4) | (3) | (4) |
| Income tax expense | – | – | 0 | 0 | – | – |
| Net income from continuing operations | – | – | (3) | (4) | – | – |
| Net income | (2) | (2) | (3) | (4) | (3) | (4) |